Human Immunodeficiency Virus-1 Subtype Distribution and Antiretroviral Drug Resistance among Treatment-naive Individuals in the Republic of Korea (2024-2025).

Public Health Wkly Rep · 2026 · PMC13228883 · PMID 42238332

Europe PMC DOI

hedged sentence

0.0390

closest p · 0.8× alpha

0.0390

boldest claim

The sentences

a decreasing trendp=0.039actually significant

Both the prevalence of resistance to at least one antiretroviral agent and the average prevalence of resistance by drug class mildly decreased in 2025 compared with 2024, and compared with previous findings (average prevalence of resistance by drug class of 5.9% in 2022–2023) [ 6 ], the average prevalence of resistance by drug class for each year shows a decreasing trend to 3.2% (p=0.039), indicating a stabilizing trend.

also in 29,529 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.